Edesa Biotech, Inc. (EDSA) Operating income 2015–2025
Edesa Biotech, Inc. (EDSA) annual operating income history from SEC filings — each fiscal year as reported.
-$7.9MFY2025 · since FY2015: -$4.3M → -$7.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.9M | -12.8% |
| FY2024 | -$7.0M | +23.9% |
| FY2023 | -$9.2M | +49.8% |
| FY2022 | -$18.4M | +22.4% |
| FY2021 | -$23.7M | -270.0% |
| FY2020 | -$6.4M | — |
| FY2018 | -$1.6M | +69.0% |
| FY2017 | -$5.2M | -6.4% |
| FY2016 | -$4.9M | -13.1% |
| FY2015 | -$4.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice